Fate Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FATE and other ETFs, options, and stocks.

About FATE

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. 

CEO
Bahram Valamehr
CEOBahram Valamehr
Employees
161
Employees161
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2007
Founded2007
Employees
161
Employees161

FATE Key Statistics

Market cap
273.80M
Market cap273.80M
Price-Earnings ratio
-2.06
Price-Earnings ratio-2.06
Dividend yield
Dividend yield
Average volume
3.09M
Average volume3.09M
High today
$2.39
High today$2.39
Low today
$1.84
Low today$1.84
Open price
$2.05
Open price$2.05
Volume
10.71M
Volume10.71M
52 Week high
$2.39
52 Week high$2.39
52 Week low
$0.91
52 Week low$0.91

Stock Snapshot

With a market cap of 273.8M, Fate Therapeutics(FATE) trades at $2.40. The stock has a price-to-earnings ratio of -2.06.

On 2026-05-06, Fate Therapeutics(FATE) stock traded between a low of $1.84 and a high of $2.39. Shares are currently priced at $2.40, which is +30.4% above the low and +0.4% below the high.

The Fate Therapeutics(FATE)'s current trading volume is 10.71M, compared to an average daily volume of 3.09M.

In the last year, Fate Therapeutics(FATE) shares hit a 52-week high of $2.39 and a 52-week low of $0.91.

In the last year, Fate Therapeutics(FATE) shares hit a 52-week high of $2.39 and a 52-week low of $0.91.

Analyst ratings

55%

of 11 ratings
Buy
54.5%
Hold
45.5%
Sell
0%

People also own

Based on the portfolios of people who own FATE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.